The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference176 articles.
1. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial;Smith;Lancet,2007
2. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer;Joensuu;N. Engl. J. Med.,2006
3. Human epidermal growth factor receptor 2 assessment in a case–control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories;Baehner;J. Clin. Oncol.,2010
4. High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study;Dabbs;J. Clin. Oncol.,2011
5. Oncotype DX test on unequivocally HER2-positive cases: potential for harm;Bhargava;J. Clin. Oncol.,2012
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characterization of HER2-Low Breast Tumors among a Cohort of Colombian Women;Cancers;2024-09-12
2. Neoadjuvant Chemotherapy of Taxanes With or Without Anthracyclines in Different Molecular Subtypes of Breast Cancer: A Propensity Score Matching Study;Clinical Breast Cancer;2023-12
3. STARD3: A New Biomarker in HER2-Positive Breast Cancer;Cancers;2023-01-05
4. Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology;Genes;2022-01-26
5. Transcriptional coactivator MED1 in the interface of anti-estrogen and anti-HER2 therapeutic resistance;Cancer Drug Resistance;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3